Journal of Interventional Cardiology / 2024 / Article / Tab 1 / Research Article
Outcomes of Drug-Eluting Stents in comparison to Bare Metal Stents in Cancer Patients with Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis Table 1 Characteristics of included studies.
Study Design Population Experimental arm Control arm Endpoints Follow-up duration Ahmed et al. [24 ] Single-center retrospective cohort study Cancer patients who underwent PCI using BMS or DES PCI using BMS PCI using DES Stent thrombosis 2 years 10 months Munawar et al. [23 ] Retrospective cohort study Patients with concomitant diagnosis of cancer undergoing PCI between January 2004 and December 2014 were identified in the National Inpatient Sample PCI using BMS PCI using DES In-hospital mortality and stent thrombosis 10 years Guo et al. [7 ] Retrospective cohort study Cancer patients undergoing PCI at Mayo Clinic Rochester from January 1, 2003, to December 31, 2013 PCI using BMS PCI using DES All-cause mortality, MI, and revascularization rate 10 years Potts et al. [25 ] Retrospective cohort study Patients undergoing PCI between January 2004 and December 2014 were identified in the National Inpatient Sample Patients with current/previous cancer undergoing PCI Patients without current/previous cancer undergoing PCI In-hospital mortality, bleeding, and stroke 10 years
BMS, bare metal stent; DES, drug-eluting stent.